• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antiviral Effects of Sinamaz®: Potentials for COVID-19 Management.

作者信息

Naseri Mohsen, Daneshfard Babak, Ravanshad Mehrdad, Nabizadeh Arezoo, Ghaffari Farzaneh

机构信息

Traditional Medicine Clinical Trial Research Center, Shahed University, Tehran, Iran.

Department of Traditional Persian Medicine, School of Medicine, Shahed University, Tehran, Iran.

出版信息

Tanaffos. 2024 Mar;23(3):217-219.

PMID:40704347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12281343/
Abstract
摘要

相似文献

1
Antiviral Effects of Sinamaz®: Potentials for COVID-19 Management.西那马斯®的抗病毒作用：对新冠病毒病的治疗潜力
Tanaffos. 2024 Mar;23(3):217-219.
2
Effect of Sinamaz nasal drop on asymptomatic family members of COVID 19 patients: An open-label randomized controlled trial.
Phytother Res. 2024 Apr;38(4):1727-1730. doi: 10.1002/ptr.7915. Epub 2023 Jul 16.
3
Targeting conserved regions of the SARS-CoV-2 polymerase (RdRp) with kinase inhibitors as an effective new tactic for discovering dual-action "antiviral-antiinflammatory" drugs against COVID-19.以激酶抑制剂靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）聚合酶（RdRp）的保守区域，作为发现针对2019冠状病毒病的双重作用“抗病毒-抗炎”药物的有效新策略。
Comput Biol Chem. 2025 Apr 11;119:108454. doi: 10.1016/j.compbiolchem.2025.108454.
4
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis.抗病毒药物治疗 2019 年冠状病毒病（COVID-19）：一项系统评价和网络荟萃分析。
Expert Rev Anti Infect Ther. 2022 Feb;20(2):267-278. doi: 10.1080/14787210.2021.1961579. Epub 2021 Aug 17.
5
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.筛选 FDA 批准的和具有生物活性的化合物库以寻找针对 SARS-CoV-2 的抗病毒活性。
ACS Infect Dis. 2021 Aug 13;7(8):2337-2351. doi: 10.1021/acsinfecdis.1c00017. Epub 2021 Jun 15.
6
Janus kinase inhibitors for the treatment of COVID-19.Janus 激酶抑制剂治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 13;6(6):CD015209. doi: 10.1002/14651858.CD015209.
7
Molnupiravir, favipiravir and other antiviral drugs with proposed potentials for management of COVID-19: a concern on antioxidant aspect.莫努匹拉韦、法匹拉韦及其他有望用于治疗新冠病毒肺炎的抗病毒药物：关于抗氧化方面的考量
Int J Biochem Mol Biol. 2022 Feb 15;13(1):1-4. eCollection 2022.
8
Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review.COVID-19 急性期中的抗病毒治疗是否能降低长新冠的风险？一项系统综述。
Infection. 2024 Feb;52(1):43-58. doi: 10.1007/s15010-023-02154-0. Epub 2023 Dec 19.
9
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis.小分子抗病毒药物治疗 COVID-19：系统评价和网络荟萃分析。
Int J Antimicrob Agents. 2024 Mar;63(3):107096. doi: 10.1016/j.ijantimicag.2024.107096. Epub 2024 Jan 18.
10
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.针对 COVID-19 的抗体和细胞疗法：一项实时系统评价和网络荟萃分析。
BMJ. 2021 Sep 23;374:n2231. doi: 10.1136/bmj.n2231.

本文引用的文献

1
The Efficacy of Herbs as Complementary and Alternative Therapy in Recovery and Clinical Outcome Among People with COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression.草药作为COVID-19患者康复和临床结局的补充和替代疗法的疗效：一项系统评价、荟萃分析和元回归分析
Ther Clin Risk Manag. 2023 Jul 18;19:611-627. doi: 10.2147/TCRM.S405507. eCollection 2023.
2
Effect of Sinamaz nasal drop on asymptomatic family members of COVID 19 patients: An open-label randomized controlled trial.
Phytother Res. 2024 Apr;38(4):1727-1730. doi: 10.1002/ptr.7915. Epub 2023 Jul 16.
3
Public Health Messages for Social Behavior Change in the Wake of COVID-19: A Qualitative Study.新冠疫情下促进社会行为改变的公共卫生信息：一项定性研究
Oman Med J. 2021 Mar 31;36(2):e254. doi: 10.5001/omj.2021.98. eCollection 2021 Mar.
4
As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention.显而易见：采用鼻腔（黏膜）途径接种疫苗预防新冠疾病的理由
Front Immunol. 2020 Sep 30;11:591897. doi: 10.3389/fimmu.2020.591897. eCollection 2020.
5
Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents.鼻腔消毒预防和控制 COVID-19：潜在化学预防剂的范围综述。
Int J Hyg Environ Health. 2020 Sep;230:113605. doi: 10.1016/j.ijheh.2020.113605. Epub 2020 Aug 18.
6
L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies.作为2019冠状病毒病潜在植物疗法的L：计算机模拟研究的小型综述
Curr Ther Res Clin Exp. 2020;93:100602. doi: 10.1016/j.curtheres.2020.100602. Epub 2020 Aug 25.
7
The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis.中药对 COVID-19 的附加作用：系统评价和荟萃分析。
Phytomedicine. 2021 May;85:153282. doi: 10.1016/j.phymed.2020.153282. Epub 2020 Jul 11.
8
Prophetic Medicine-Nigella Sativa (Black cumin seeds) - Potential herb for COVID-19?预言性医学——黑种草（黑孜然籽）——治疗新冠病毒病的潜在草药？
J Pharmacopuncture. 2020 Jun 30;23(2):62-70. doi: 10.3831/KPI.2020.23.010.
9
Epidemiology of COVID-19 Infection in Oman: Analysis of the First 1304 Cases.阿曼新型冠状病毒肺炎感染的流行病学：对首批1304例病例的分析。
Oman Med J. 2020 Jun 30;35(3):e145. doi: 10.5001/omj.2020.60. eCollection 2020 May.
10
Overview of therapeutic drug research for COVID-19 in China.中国针对 COVID-19 的治疗药物研究概述。
Acta Pharmacol Sin. 2020 Sep;41(9):1133-1140. doi: 10.1038/s41401-020-0438-y. Epub 2020 Jun 17.